Lovat LB - Search Results

1

Gastrin-induced cyclooxygenase-2 expression in Barrett's carcinogenesis.

Abdalla SI, Lao-Sirieix P, Novelli MR, Lovat LB, Sanderson IR, Fitzgerald RC. Abdalla SI, et al. Among authors: lovat lb. Clin Cancer Res. 2004 Jul 15;10(14):4784-92. doi: 10.1158/1078-0432.CCR-04-0015. Clin Cancer Res. 2004. PMID: 15269153

2

Significance of genetic abnormalities after photodynamic therapy.

Fitzgerald RC, Lovat L. Fitzgerald RC, et al. Gastroenterology. 2001 Mar;120(4):1064-5; author reply1065-6. doi: 10.1053/gast.2001.23099. Gastroenterology. 2001. PMID: 11265670 No abstract available.

3

Cell cycle phase abnormalities do not account for disordered proliferation in Barrett's carcinogenesis.

Lao-Sirieix P, Brais R, Lovat L, Coleman N, Fitzgerald RC. Lao-Sirieix P, et al. Neoplasia. 2004 Nov-Dec;6(6):751-60. doi: 10.1593/neo.04280. Neoplasia. 2004. PMID: 15720801 Free PMC article.

4

Photodynamic therapy with m-tetrahydroxyphenyl chlorin for high-grade dysplasia and early cancer in Barrett's columnar lined esophagus.

Lovat LB, Jamieson NF, Novelli MR, Mosse CA, Selvasekar C, Mackenzie GD, Thorpe SM, Bown SG. Lovat LB, et al. Gastrointest Endosc. 2005 Oct;62(4):617-23. doi: 10.1016/j.gie.2005.04.043. Gastrointest Endosc. 2005. PMID: 16185985

5

Elastic scattering spectroscopy for the diagnosis of colonic lesions: initial results of a novel optical biopsy technique.

Dhar A, Johnson KS, Novelli MR, Bown SG, Bigio IJ, Lovat LB, Bloom SL. Dhar A, et al. Among authors: lovat lb. Gastrointest Endosc. 2006 Feb;63(2):257-61. doi: 10.1016/j.gie.2005.07.026. Gastrointest Endosc. 2006. PMID: 16427931

6

Elastic scattering spectroscopy accurately detects high grade dysplasia and cancer in Barrett's oesophagus.

Lovat LB, Johnson K, Mackenzie GD, Clark BR, Novelli MR, Davies S, O'Donovan M, Selvasekar C, Thorpe SM, Pickard D, Fitzgerald R, Fearn T, Bigio I, Bown SG. Lovat LB, et al. Gut. 2006 Aug;55(8):1078-83. doi: 10.1136/gut.2005.081497. Epub 2006 Feb 9. Gut. 2006. PMID: 16469795 Free PMC article.

7

Cyclin A immunocytology as a risk stratification tool for Barrett's esophagus surveillance.

Lao-Sirieix P, Lovat L, Fitzgerald RC. Lao-Sirieix P, et al. Clin Cancer Res. 2007 Jan 15;13(2 Pt 1):659-65. doi: 10.1158/1078-0432.CCR-06-1385. Clin Cancer Res. 2007. PMID: 17255290 Free article.

8

How light dosimetry influences the efficacy of photodynamic therapy with 5-aminolaevulinic acid for ablation of high-grade dysplasia in Barrett's esophagus.

Mackenzie GD, Jamieson NF, Novelli MR, Mosse CA, Clark BR, Thorpe SM, Bown SG, Lovat LB. Mackenzie GD, et al. Among authors: lovat lb. Lasers Med Sci. 2008 Apr;23(2):203-10. doi: 10.1007/s10103-007-0473-7. Epub 2007 Jul 3. Lasers Med Sci. 2008. PMID: 17610005

9

Optimal conditions for successful ablation of high-grade dysplasia in Barrett's oesophagus using aminolaevulinic acid photodynamic therapy.

Mackenzie GD, Dunn JM, Selvasekar CR, Mosse CA, Thorpe SM, Novelli MR, Bown SG, Lovat LB. Mackenzie GD, et al. Among authors: lovat lb. Lasers Med Sci. 2009 Sep;24(5):729-34. doi: 10.1007/s10103-008-0630-7. Epub 2008 Dec 5. Lasers Med Sci. 2009. PMID: 19057983 Clinical Trial.

10

SIRT--an uncommon cause of gastroduodenal ulceration.

Silvanto A, Novelli M, Lovat L. Silvanto A, et al. Histopathology. 2009 Jul;55(1):114-5. doi: 10.1111/j.1365-2559.2009.03333.x. Histopathology. 2009. PMID: 19614774 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

239 results

Search Page

Filters